Trials / Conditions / T-cell Adult Acute Lymphoblastic Leukemia

T-cell Adult Acute Lymphoblastic Leukemia

11 registered clinical trials studyying T-cell Adult Acute Lymphoblastic Leukemia.

Status	Trial	Sponsor	Phase
Unknown	Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old) NCT02619630	Assistance Publique - Hôpitaux de Paris	Phase 2
Completed	Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Old NCT02228772	Massachusetts General Hospital	Phase 1
Completed	CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lym NCT02168140	Wake Forest University Health Sciences	Phase 1
Completed	Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing NCT01588015	City of Hope Medical Center	Phase 1
Completed	Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma NCT01258998	National Cancer Institute (NCI)	Phase 2
Completed	Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hod NCT00918333	Mayo Clinic	Phase 1 / Phase 2
Completed	Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia NCT00873093	National Cancer Institute (NCI)	Phase 2
Completed	Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies NCT01093586	Case Comprehensive Cancer Center	Phase 2
Completed	7-Hydroxystaurosporine and Perifosine in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic NCT00301938	National Cancer Institute (NCI)	Phase 1
Completed	Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia NCT00061945	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Biological Therapy in Treating Patients With Advanced Myelodysplastic Syndrome, Acute or Chronic Myeloid Leuke NCT00052520	Fred Hutchinson Cancer Center	Phase 1 / Phase 2